Variant report
Variant | esv3350422 |
---|---|
Chromosome Location | chr3:163858299-163883405 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs73172621 | chr3:163858319-163858320 | Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs535755471 | chr3:163858326-163858327 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs377508860 | chr3:163858334-163858335 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs565697685 | chr3:163858383-163858384 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs569780009 | chr3:163858412-163858413 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs553478634 | chr3:163858432-163858433 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs370566006 | chr3:163858470-163858471 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs528935657 | chr3:163858471-163858472 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs1349607 | chr3:163858483-163858484 | Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs556327067 | chr3:163858494-163858495 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs115862629 | chr3:163858503-163858504 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs557864473 | chr3:163858518-163858519 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs75264778 | chr3:163858521-163858522 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs565505440 | chr3:163858547-163858548 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs1349285 | chr3:163858560-163858561 | Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs116782773 | chr3:163858581-163858582 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs192642704 | chr3:163858617-163858618 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs557663652 | chr3:163858620-163858621 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs144577203 | chr3:163858624-163858625 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs549261430 | chr3:163858643-163858644 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs563141110 | chr3:163858670-163858671 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs531899569 | chr3:163858704-163858705 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs528015556 | chr3:163858878-163858879 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs572057475 | chr3:163858917-163858918 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs10804812 | chr3:163858926-163858927 | Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs62280776 | chr3:163858937-163858938 | Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs367756795 | chr3:163858965-163858966 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs547004853 | chr3:163858985-163858986 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs200082607 | chr3:163858993-163858994 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs139422200 | chr3:163859021-163859022 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs183138415 | chr3:163859080-163859081 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs556076303 | chr3:163859106-163859107 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs372696027 | chr3:163859111-163859112 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs538915223 | chr3:163859112-163859113 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs143550585 | chr3:163859220-163859221 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs572389249 | chr3:163859250-163859251 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs540594534 | chr3:163859256-163859257 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs188251985 | chr3:163859319-163859320 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs574646117 | chr3:163859343-163859344 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs73172622 | chr3:163859344-163859345 | Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs146309156 | chr3:163859349-163859350 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs562927577 | chr3:163859388-163859389 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs192169711 | chr3:163859389-163859390 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs545220089 | chr3:163859397-163859398 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs565205142 | chr3:163859473-163859474 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs527988126 | chr3:163859476-163859477 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs184381454 | chr3:163859480-163859481 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs139597311 | chr3:163859482-163859483 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs529737316 | chr3:163859563-163859564 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs142888637 | chr3:163859566-163859567 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malformation | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
epilepsy | 18472482 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Parkinson disease | 21907011 | CNVD |
Bladder cancer | 21909424 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Cancer | 20164919 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:163854600-163862000 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr3:163860000-163861400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr3:163862000-163870200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr3:163863200-163866400 | ZNF genes & repeats | HUES64 Cell Line | embryonic stem cell |
5 | chr3:163865800-163867600 | ZNF genes & repeats | H1 Cell Line | embryonic stem cell |
6 | chr3:163868200-163870200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
7 | chr3:163870200-163874600 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr3:163873400-163873800 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
9 | chr3:163874600-163879600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr3:163875800-163876200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr3:163879600-163898800 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr3:163881400-163881600 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |